Plex Research was founded on the notion that more data should mean better medicines. To accomplish that goal, Plex is making the world's scientific data findable, accessible, searchable, and transparent from a single location.
Lab-to-Launch Lounge
Wednesday, September 18, 2024
Dr. Douglas Selinger is the CEO and Founder of Plex Research. As an early pioneer of microarray technology, Doug authored some of the first publications describing experimental and computational approaches for large scale transcriptional analyses. After completing his Ph.D. in George Church’s lab at Harvard, he joined the Novartis Institutes for Biomedical Research where his 14-year career spanned the entire drug discovery pipeline, including significant work in target ID/validation, high throughput screening, and preclinical safety. In 2017, Doug founded Plex Research to develop a novel form of AI based on search engine algorithms. Plex’s unique platform has helped dozens of biotech and pharma companies accelerate their drug discovery pipelines by providing interpretable and actionable analyses of massive chemical biology and omics data sets.
